Equity Details
Price & Market Data
Price: $3.47
Daily Change: -$0.253 / 7.29%
Daily Range: $3.35 - $4.14
Market Cap: $25,304,200
Daily Volume: 491,885
Performance Metrics
1 Week: -10.80%
1 Month: -11.03%
3 Months: -12.99%
6 Months: -51.30%
1 Year: -90.14%
YTD: -50.83%
About BriaCell Therapeutics Corp. (BCTX)
Get immediate market data for BriaCell Therapeutics Corp. (BCTX). Price: 3.47, daily change: -$0.253 / 7.29%. Market cap: 25,304,200. All performance metrics at your fingertips.
Company Details
Employees: 17
Sector: Health technology
Industry: Biotechnology
Country: Canada
Details
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the
clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.
